Cryptococcosis in the acquired immunodeficiency syndrome

Area of Science:

• Infectious Diseases
• Immunology
• Clinical Medicine

Background:

• Cryptococcosis is a significant opportunistic infection in individuals with acquired immunodeficiency syndrome (AIDS).
• It frequently presents as the initial manifestation or an early opportunistic infection in AIDS patients.
• Meningitis is the most common clinical presentation of cryptococcosis in this population.

Purpose of the Study:

• To review the clinical course and treatment response of cryptococcosis in patients with AIDS.
• To evaluate the effectiveness of conventional therapies for cryptococcosis in AIDS patients.
• To identify factors influencing prognosis and suggest potential improvements in patient management.

Main Methods:

• Retrospective review of 27 patients diagnosed with cryptococcosis and AIDS.
• Analysis of clinical features, laboratory findings (blood, cerebrospinal fluid), and diagnostic test results.
• Assessment of treatment regimens, including amphotericin B and flucytosine, and patient outcomes.

Main Results:

• Cryptococcosis was the initial or an early opportunistic infection in 14 out of 27 patients.
• Meningitis occurred in 18 patients, often with normal cerebrospinal fluid parameters except for positive India ink, culture, and antigen tests.
• Conventional therapy with amphotericin B alone or with flucytosine showed limited efficacy, with a high rate of relapse (60% in those without initial clinical activity).

Conclusions:

• Cryptococcosis in AIDS patients is a severe, debilitating illness with a poor response to standard antifungal therapies.
• Early diagnosis and consideration of long-term suppressive therapy are crucial for improving patient prognosis.
• Further research into novel therapeutic strategies is warranted for managing this opportunistic infection in immunocompromised individuals.